RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Eczematous Skin Diseases
Accession: DOID:9004383
browse the term
Definition: Any of a variety of eruptive skin disorders characterized by erythema, oozing, vesiculation, and scaling. Etiology is varied.
Synonyms: exact_synonym: Eczematous Disorder; Eczematous Disorders; Eczematous Skin Disease
primary_id: MESH:D017443
alt_id: RDO:0005345
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abca6
ATP binding cassette subfamily A member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr10:95,142,805...95,212,087
Ensembl chr10:95,142,966...95,211,530
G
Asrgl1
asparaginase and isoaspartyl peptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 1:206,006,103...206,027,115
Ensembl chr 1:206,006,109...206,027,108
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr13:22,689,783...22,853,920
G
Bmp6
bone morphogenetic protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr17:26,318,121...26,469,034
Ensembl chr17:26,318,569...26,470,365
G
Calcrl
calcitonin receptor like receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 3:69,428,348...69,525,910
Ensembl chr 3:69,430,120...69,525,910
G
Casp8
caspase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Ccl17
C-C motif chemokine ligand 17
ISO
RGD
PMID:15491423
RGD:1626251
NCBI chr19:10,202,317...10,203,768
Ensembl chr19:10,202,128...10,203,819
G
Ccl19
C-C motif chemokine ligand 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased expression:ear (mouse)
RGD
PMID:15491423
RGD:1626251
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
G
Ccr1
C-C motif chemokine receptor 1
ISO
RGD
PMID:18844696
RGD:5688176
NCBI chr 8:123,556,286...123,561,841
G
Ccr2
C-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17374397 PMID:10899907
RGD:8661227
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:22075493
RGD:6892916
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccr5
C-C motif chemokine receptor 5
IEP
mRNA:increased expression:skin, lymph node (rat)
RGD
PMID:16977379
RGD:2325935
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd36
CD36 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd3d
CD3 delta subunit of T-cell receptor complex
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr 8:45,287,803...45,293,342
Ensembl chr 8:45,288,749...45,301,809
G
Cidec
cell death-inducing DFFA-like effector c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
G
Cish
cytokine inducible SH2-containing protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
G
Cntn3
contactin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr 4:134,841,268...135,214,460
Ensembl chr 4:134,842,266...135,125,613
G
Crem
cAMP responsive element modulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
G
Ctsc
cathepsin C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23178550
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11312644 PMID:19022366
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Emb
embigin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050
G
Ets2
ETS proto-oncogene 2, transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
G
F13a1
coagulation factor XIII A1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
G
Fgl2
fibrinogen-like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
G
Flt1
Fms related receptor tyrosine kinase 1
ISO
mRNA:protein:skin:
RGD
PMID:7876550
RGD:7421586
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Fyb1
FYN binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 2:55,621,585...55,781,206
Ensembl chr 2:55,632,698...55,779,629
G
Grk2
G protein-coupled receptor kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 1:201,581,480...201,601,580
Ensembl chr 1:201,581,480...201,601,582
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
G
Ifi30
IFI30, lysosomal thiol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr16:18,675,651...18,679,857
Ensembl chr16:18,675,613...18,681,175
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11312644 PMID:12484431 PMID:15347381
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igsf6
immunoglobulin superfamily, member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 1:175,610,167...175,620,662
Ensembl chr 1:175,610,167...175,620,722
G
Il10
interleukin 10
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15347381 PMID:23760007
RGD:7364806
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
treatment
ISO
mRNA:increased expression:skin CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27585668 PMID:9781803 PMID:12874202
RGD:8655902 , RGD:8655940
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il18bp
interleukin 18 binding protein
treatment
ISO
RGD
PMID:12874202
RGD:8655940
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23178550
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il2
interleukin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11312644 PMID:22245253
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il2ra
interleukin 2 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12484431 PMID:21804303
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15347381
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Ipcef1
interaction protein for cytohesin exchange factors 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 1:43,237,903...43,451,735
Ensembl chr 1:43,269,202...43,427,969
G
Itgam
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 1:182,659,047...182,709,495
Ensembl chr 1:182,659,000...182,709,503
G
Jam2
junctional adhesion molecule 2
ISO
RGD
PMID:16297198
RGD:7488919
NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063
G
Jam3
junctional adhesion molecule 3
ISO
RGD
PMID:16297198
RGD:7488919
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
G
Kdr
kinase insert domain receptor
ISO
mRNA:protein:skin:
RGD
PMID:7876550
RGD:7421586
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kmo
kynurenine 3-monooxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
G
Mc1r
melanocortin 1 receptor
ISO
RGD
PMID:20126537
RGD:5687319
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Meox1
mesenchyme homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
G
Mir155
microRNA 155
treatment
IEP
RGD
PMID:29404871
RGD:21079472
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
treatment
IEP
RGD
PMID:29282578
RGD:41404666
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mki67
marker of proliferation Ki-67
ISO
RGD
PMID:21294775
RGD:6483538
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mmp3
matrix metallopeptidase 3
IEP ISO
mRNA:increased expression:skin, lymph node
RGD
PMID:16977379 PMID:10359808
RGD:2325935 , RGD:8693317
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
IEP ISO
mRNA:increased expression:skin, lymph node
RGD
PMID:16977379 PMID:10359808 PMID:10415717
RGD:2325935 , RGD:8693317 , RGD:8547869
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mrc1
mannose receptor, C type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
G
Mxd1
max dimerization protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
G
Nampt
nicotinamide phosphoribosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Nat1
N-acetyltransferase 1
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:19663877
RGD:8552666
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
G
Nat2
N-acetyltransferase 2
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:16533241
RGD:8552663
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23564646
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
G
Ninj1
ninjurin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
G
Numa1
nuclear mitotic apparatus protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 1:156,297,907...156,372,855
Ensembl chr 1:156,326,259...156,372,855
G
Ogg1
8-oxoguanine DNA glycosylase
ISO
RGD
PMID:15677345
RGD:8657146
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Phlda1
pleckstrin homology-like domain, family A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Pim1
Pim-1 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Prdx4
peroxiredoxin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr X:40,026,762...40,044,066
Ensembl chr X:40,026,651...40,044,066
G
Qpct
glutaminyl-peptide cyclotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 6:15,964,656...15,996,925
Ensembl chr 6:15,964,657...15,996,711
G
Rab32
RAB32, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 1:4,946,193...4,961,003
Ensembl chr 1:4,945,036...4,960,934
G
Rgs1
regulator of G-protein signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr13:56,018,529...56,022,939
Ensembl chr13:56,018,554...56,022,984
G
Sat1
spermidine/spermine N1-acetyl transferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Sele
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Slc2a3
solute carrier family 2 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc7a5
solute carrier family 7 member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374397
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Socs1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Socs2
suppressor of cytokine signaling 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14555839
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
St6gal1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310
G
Stac
SH3 and cysteine rich domain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr 8:111,530,800...111,653,228
Ensembl chr 8:111,530,800...111,654,008
G
Tap2
transporter 2, ATP binding cassette subfamily B member
susceptibility
ISO
RGD
PMID:9303338
RGD:6482276
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
G
Tlr4
toll-like receptor 4
ISO
RGD
PMID:20711192 PMID:18725520
RGD:7777133 , RGD:7794737
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr7
toll-like receptor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr X:27,027,380...27,054,309
Ensembl chr X:27,027,425...27,054,754
G
Tmsb10
thymosin, beta 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17597826
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15849067
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip6
TNF alpha induced protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404 PMID:17374397
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tslp
thymic stromal lymphopoietin
treatment
ISO
RGD
PMID:30187507
RGD:38596345
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Upp1
uridine phosphorylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16033404
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Vegfa
vascular endothelial growth factor A
IEP ISO
mRNA:protein:skin:
RGD
PMID:7876550 PMID:7876550
RGD:7421586 , RGD:7421586
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Actl9
actin-like 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr 7:14,234,504...14,235,881
Ensembl chr 7:14,234,504...14,235,881
G
Adam17
ADAM metallopeptidase domain 17
ISS
OMIM:603165
MouseDO
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Apoe
apolipoprotein E
ISO
protein:decreased expression:plasma
RGD
PMID:19116453
RGD:11040546
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Artn
artemin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr 5:131,458,596...131,470,193
Ensembl chr 5:131,464,756...131,468,025
G
Bdnf
brain-derived neurotrophic factor
susceptibility no_association
ISO
DNA:polymorphism::C270T(human) protein:increased expression:serum: DNA:polymorphism:cds:p.V66M(human) mRNA:decreased expression:mast cell
RGD
PMID:19522715 PMID:17073871 PMID:19038326 PMID:17845420
RGD:8657028 , RGD:8657069 , RGD:8657067 , RGD:8657065
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
C3
complement C3
ISO
protein:increased expression:plasma
RGD
PMID:3923750
RGD:7401273
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Card11
caspase recruitment domain family, member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114 PMID:28628108
NCBI chr12:13,620,979...13,758,115
Ensembl chr12:13,621,087...13,758,112
G
Casp8
caspase 8
ISS
OMIM:603165
MouseDO
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Ccdc80
coiled-coil domain containing 80
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
G
Ccl11
C-C motif chemokine ligand 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl17
C-C motif chemokine ligand 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr19:10,202,317...10,203,768
Ensembl chr19:10,202,128...10,203,819
G
Ccl20
C-C motif chemokine ligand 20
severity treatment
ISO
protein:increased expression:plasma
RGD
PMID:11133838 PMID:19162238
RGD:7483580 , RGD:7483583
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl22
C-C motif chemokine ligand 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437 PMID:22125604
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl24
C-C motif chemokine ligand 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
G
Ccl26
C-C motif chemokine ligand 26
ISO
protein:increased expression:serum (human)
RGD
PMID:14616792
RGD:11087554
NCBI chr12:21,109,384...21,114,336
Ensembl chr12:21,109,421...21,114,335
G
Ccl27
C-C motif chemokine ligand 27
ISO
RGD
PMID:12642842
RGD:1626250
NCBI chr 5:56,941,402...56,948,511
Ensembl chr 5:56,941,402...56,948,506
G
Ccl28
C-C motif chemokine ligand 28
severity
ISO
associated with Asthma; protein: increased secretion:serum (human)
RGD
PMID:20161852
RGD:4892193
NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997
G
Ccl5
C-C motif chemokine ligand 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
G
Ccr2
C-C motif chemokine receptor 2
ISO
protein:increased expression:skin,monocyte:
RGD
PMID:15370700
RGD:8661734
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr3
C-C motif chemokine receptor 3
ISO
protein:increased expression:skin CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18249437 PMID:16449815
RGD:6893391
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccr5
C-C motif chemokine receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18249437 PMID:16449815
RGD:6893391
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd40
CD40 molecule
ISO
RGD
PMID:18693155
RGD:5132274
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cdsn
corneodesmosin
ISO
protein:decreased expression:skin of body (human)
RGD
PMID:21211653
RGD:42721970
NCBI chr20:3,179,432...3,185,854
Ensembl chr20:3,179,438...3,184,250
G
Cldn1
claudin 1
ISO
mRNA,protein:decreased expression:epidermis; DNA:SNPs:intron,promoter :rs17501010,rs9290927,rs893051,rs9290929,rs16865373(human)
RGD
PMID:21163515
RGD:11344875
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Cldn23
claudin 23
ISO
mRNA:decreased expression:epidermis:
RGD
PMID:21163515
RGD:11344875
NCBI chr16:56,413,677...56,415,401
Ensembl chr16:56,413,381...56,415,523
G
Cma1
chymase 1
ISO
DNA:polymorphism:5' utr:g.-1903G>A rs1800875 (human)
RGD
PMID:16134991
RGD:1625394
NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO
DNA:SNP,haplotype:exon,3'UTR:rs3087243,rs231775 (human) mRNA:increased expression:blood:
RGD
PMID:16445777 PMID:22357516
RGD:7411698 , RGD:7411700
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Ctse
cathepsin E
ISS
OMIM:603165
MouseDO
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
protein:increased expression:serum
RGD
PMID:15131578
RGD:9491761
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO
protein:decreased expression:blood, leukocyte
RGD
PMID:24821910 PMID:15131578
RGD:9491393 , RGD:9491761
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp4f39
cytochrome P450, family 4, subfamily f, polypeptide 39
ISO
ClinVar Annotator: match by term: Atopic eczema
ClinVar
PMID:25741868
NCBI chr 7:11,426,806...11,505,553
Ensembl chr 7:11,433,371...11,536,181
G
Dock8
dedicator of cytokinesis 8
ISO
DNA:mutations:cds:
RGD
PMID:22476911
RGD:40903056
NCBI chr 1:222,649,309...222,842,474
Ensembl chr 1:222,649,309...222,842,474
G
Emsy
EMSY transcriptional repressor, BRCA2 interacting
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr 1:152,881,485...152,960,420
Ensembl chr 1:152,883,992...152,953,528
G
F2
coagulation factor II
ISO
protein:increased expression:plasma
RGD
PMID:21488867
RGD:5147756
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fcgr2a
Fc gamma receptor 2A
severity
ISO
protein:increased expression:eosinophil
RGD
PMID:7564170 PMID:19414806
RGD:5147985 , RGD:5508430
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Flg
filaggrin
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Atopic eczema
CTD ClinVar
PMID:16444271 PMID:16550169 PMID:16815158 PMID:17030239 PMID:17417636 PMID:17657246 PMID:18325573 PMID:19349982 PMID:19501237 PMID:19538357 PMID:19733298 PMID:19785597 PMID:19839980 PMID:19874431 PMID:20426775 PMID:20573035 PMID:21365004 PMID:21377035 PMID:21514438 PMID:21564328 PMID:21777221 PMID:22403702 PMID:22995991 PMID:23039796 PMID:23042114 PMID:23166590 PMID:23343419 PMID:23348739 PMID:23352160 PMID:23947670 PMID:23993222 PMID:24033266 PMID:24061166 PMID:24251354 PMID:24920311 PMID:25333069 PMID:25741868 PMID:26451970 PMID:27279822 PMID:27363669 PMID:27462351 PMID:28164424 PMID:28213896 PMID:28730607 PMID:29054605 PMID:29068602 PMID:29428354 PMID:29431110 PMID:29444371 PMID:29791750 PMID:30665703 PMID:31637781 More...
NCBI chr 2:178,888,688...178,912,731
G
Glb1
galactosidase, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:21176116 PMID:20674822
RGD:5490539 , RGD:5490981
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
susceptibility
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:19842992 PMID:20674822
RGD:5490540 , RGD:5490981
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
ISO
DNA:deletion, haplotype: :
RGD
PMID:19842992
RGD:5490540
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Havcr1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:16159638
RGD:5128852
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hnmt
histamine N-methyltransferase
ISO
RGD
PMID:19025430
RGD:5128889
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18249437 PMID:22101570
RGD:8157618
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifnl3
interferon, lambda 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22295096
NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096
G
Il10
interleukin 10
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18249437 PMID:23843958
RGD:7364805
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
severity treatment
ISO
DNA:SNPs: :rs3091307, rs20541 (human) CTD Direct Evidence: marker/mechanism DNA:SNP:exon:4257G>A (human) DNA, protein:SNP, increased expression:promoter, serum:-1112C>T (human)
CTD RGD
PMID:18249437 PMID:22355542 PMID:21913997 PMID:16672002 PMID:17313488 PMID:19006098 PMID:10887320 PMID:23317483 More...
RGD:5684364 , RGD:8549583 , RGD:8549539 , RGD:8549531 , RGD:8549529 , RGD:8549509
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il13ra1
interleukin 13 receptor subunit alpha 1
ISO
mRNA:increased expression:skin
RGD
PMID:14527737
RGD:8549525
NCBI chr X:115,348,860...115,408,682
Ensembl chr X:115,348,860...115,408,681
G
Il13ra2
interleukin 13 receptor subunit alpha 2
ISO
protein:increased expression:serum
RGD
PMID:21462799 PMID:20971924
RGD:8549521 , RGD:8549556
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
G
Il17a
interleukin 17A
treatment severity
ISO
protein:increased expression:dermis, lymphocyte (human) protein:increased expression:epidermis (mouse)
RGD
PMID:24337738 PMID:18432274 PMID:22848348
RGD:8698670 , RGD:9068436 , RGD:9068417
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
severity no_association
ISO ISS
protein:increased expression:serum OMIM:603165 DNA:SNP:promoter:-140C>G (rs360721) (human) DNA:SNP:promoter:-137G>C (rs187238) (human) DNA:SNPs, haplotype: :rs795467, rs4937113, rs5744247 (human)
MouseDO RGD
PMID:15317323 PMID:22840759 PMID:22840759 PMID:11490156 PMID:17517100
RGD:8655872 , RGD:8655914 , RGD:8655914 , RGD:8655908 , RGD:8655876
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
susceptibility
ISO
associated with food hypersensitivity; protein:increased expression:CD8+ T cell: DNA:SNP:promoter:rs2069762(human)
RGD
PMID:7547077 PMID:1673687 PMID:16672002 PMID:16333313 PMID:21982597
RGD:8662961 , RGD:8693325 , RGD:8549583 , RGD:8663473 , RGD:8663444
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il21r
interleukin 21 receptor
ISO
protein:increased expression:skin
RGD
PMID:19075398 PMID:19075398
RGD:6892938 , RGD:6892938
NCBI chr 1:180,168,028...180,195,690
Ensembl chr 1:180,168,097...180,195,522
G
Il25
interleukin 25
ISO
protein:increased expression:arm skin
RGD
PMID:23657503
RGD:39128244
NCBI chr15:28,408,842...28,411,676
Ensembl chr15:28,408,842...28,411,893
G
Il31
interleukin 31
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr12:33,095,108...33,105,026
Ensembl chr12:33,092,097...33,105,037
G
Il33
interleukin 33
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il4
interleukin 4
ISO
DNA:SNP:promoter:-590C>T (human) CTD Direct Evidence: marker/mechanism protein:increased expression:serum
CTD RGD
PMID:11886533 PMID:12230500 PMID:18249437 PMID:9643293 PMID:8363440
RGD:7829786 , RGD:7829795
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il4r
interleukin 4 receptor
susceptibility
ISO
DNA:mutation:cds:p.Q576R(human)
RGD
PMID:9392697
RGD:11530001
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il5
interleukin 5
ISO
mRNA: increased expression: skin CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11886533 PMID:18249437 PMID:22299064
RGD:5687175
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18249437
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
ISO
ClinVar Annotator: match by term: Atopic eczema
ClinVar
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
G
Mapk8
mitogen-activated protein kinase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24046278
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mbl2
mannose binding lectin 2
susceptibility
ISO
DNA:polymorphisms:promoter, exon:
RGD
PMID:20642202
RGD:8693720
NCBI chr 1:228,016,439...228,024,736
G
Mc1r
melanocortin 1 receptor
ISO
protein: increased expression: skin
RGD
PMID:19889022
RGD:5687321
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Mmp9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:27776525
RGD:13204759
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Ms4a2
membrane spanning 4-domains A2
susceptibility
ISO
Atopy and bronchial hyperresponsiveness, OMIM:147050 Atopy and bronchial hyperresponsiveness, OMIM:147050 DNA:polymorphism:CDS:amino acid E237G
RGD
PMID:8817330 PMID:8817330
RGD:1599903 , RGD:1599903
NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310
G
Nat2
N-acetyltransferase 2
susceptibility no_association
ISO
DNA:polymorphisms: :481C>T, 590G>A(human) DNA:polymorphisms: :481C>T,590G>A,857G>A(human)
RGD
PMID:16224574 PMID:14528063
RGD:8552664 , RGD:8552668
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Nfkbia
NFKB inhibitor alpha
ISS
OMIM:603165
MouseDO
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbiz
NFKB inhibitor zeta
ISS
OMIM:603165
MouseDO
NCBI chr11:44,782,676...44,810,723
Ensembl chr11:44,782,676...44,810,723
G
Ngf
nerve growth factor
ISO
protein:increased expression:serum:
RGD
PMID:17073871
RGD:8657069
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
ISO
protein:increased expression:nerve fibers of the papillary dermis (human)
RGD
PMID:16586073
RGD:5508452
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
ISO
protein:increased expression:eosinophil
RGD
PMID:18647313 PMID:17223862
RGD:5144116 , RGD:5684771
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
G
Ovol1
ovo like transcriptional repressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23042114
NCBI chr 1:202,855,261...202,868,858
Ensembl chr 1:202,855,265...202,866,831
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
potential therapeutic target with or without glucocorticoid therapy (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18249437 PMID:21633371
RGD:5509940
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppia
peptidylprolyl isomerase A
ISO
mRNA:increased expression:zone of skin (human)
RGD
PMID:32496587
RGD:150383342
NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601
G
Relb
RELB proto-oncogene, NF-kB subunit
ISO ISS
OMIM:603165
MouseDO RGD
PMID:10940923
RGD:7777149
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
S100a8
S100 calcium binding protein A8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18336422
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
Sele
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12410700
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Selp
selectin P
ISO
atopy and bronchial hyperresponsiveness, OMIM:147050
RGD
PMID:12929084
RGD:1599904
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Sharpin
SHANK-associated RH domain interactor
ISS
OMIM:603165
MouseDO
NCBI chr 7:108,070,681...108,075,012
Ensembl chr 7:108,070,687...108,074,955
G
Slc11a1
solute carrier family 11 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16597321
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Stat6
signal transducer and activator of transcription 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15306842
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Tgfb1
transforming growth factor, beta 1
ISO
GAD RGD
PMID:15118671 PMID:11496247
RGD:1331525 , RGD:7394812
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tlr2
toll-like receptor 2
severity
ISO
DNA:polymorphism: :-16934A>T(human) DNA:polymorphism:cds:p.R753Q(human)
RGD
PMID:19627277 PMID:22032785 PMID:17531301
RGD:8552997 , RGD:8553048 , RGD:8552999
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
ISO
DNA:polymorphism: :896G>A(human) mRNA:increased expression:blood cell:
RGD
PMID:23821954 PMID:19764566
RGD:7794689 , RGD:7794745
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tmem79
transmembrane protein 79
ISS
OMIM:603165
MouseDO
NCBI chr 2:173,798,267...173,803,151
Ensembl chr 2:173,798,267...173,803,046
G
Tnf
tumor necrosis factor
susceptibility
ISO
DNA:haplotype:promoter:−308G>A,-238G>A(human)
RGD
PMID:22533231
RGD:7401246
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip6
TNF alpha induced protein 6
ISO
mRNA:altered expression:fibroblast
RGD
PMID:16650051
RGD:7777183
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Traf3ip2
Traf3 interacting protein 2
ISS
OMIM:603165
MouseDO
NCBI chr20:43,011,405...43,054,654
Ensembl chr20:43,011,450...43,054,667
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
ISS
OMIM:603165
MouseDO
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
G
Tslp
thymic stromal lymphopoietin
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16880407 PMID:22355542 PMID:23688403 PMID:27869817 PMID:29310423
RGD:38549374
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Vdr
vitamin D receptor
severity no_association
ISO
DNA:SNPs, haplotype: :rs731236, rs1544410, rs7975232 (human) DNA:SNP: :rs2228570 (human)
RGD
PMID:23034014 PMID:23034014
RGD:8157625 , RGD:8157625
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vnn1
vanin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19322213
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
G
Wasl
WASP like actin nucleation promoting factor
ISS
OMIM:603165
MouseDO
NCBI chr 4:53,083,536...53,132,061
Ensembl chr 4:53,083,536...53,132,022
G
Flg
filaggrin
susceptibility
ISO
ClinVar Annotator: match by term: Atopic dermatitis 2 | ClinVar Annotator: match by term: Dermatitis, atopic, 2, susceptibility to CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:16444271 PMID:16550169 PMID:16815158 PMID:17030239 PMID:17291859 PMID:17417636 PMID:17657246 PMID:18325573 PMID:18396323 PMID:19183181 PMID:19501237 PMID:19538357 PMID:19733298 PMID:19785597 PMID:19839980 PMID:19874431 PMID:20426775 PMID:20573035 PMID:20674819 PMID:21039602 PMID:21365004 PMID:21377035 PMID:21514438 PMID:21564328 PMID:21777221 PMID:22403702 PMID:22407025 PMID:22951058 PMID:22995991 PMID:23039796 PMID:23166590 PMID:23343419 PMID:23352160 PMID:23947670 PMID:23993222 PMID:24033266 PMID:24251354 PMID:24565632 PMID:24920311 PMID:25314673 PMID:25333069 PMID:25741868 PMID:26451970 PMID:27279822 PMID:27363669 PMID:27462351 PMID:28143684 PMID:28164424 PMID:28213896 PMID:28730607 PMID:29054605 PMID:29068602 PMID:29428354 PMID:29431110 PMID:29444371 PMID:29791750 PMID:30665703 PMID:31365035 PMID:31637781 More...
NCBI chr 2:178,888,688...178,912,731
G
Socs3
suppressor of cytokine signaling 3
susceptibility
ISO
OMIM
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Dsg1
desmoglein 1
ISO
ClinVar Annotator: match by term: Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige | ClinVar Annotator: match by term: SAM SYNDROME
OMIM ClinVar
PMID:23974871 PMID:24033266 PMID:25741868 PMID:28492532
NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443
G
Ager
advanced glycosylation end product-specific receptor
ISO
RGD
PMID:23594597
RGD:8695987
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Akr1b10
aldo-keto reductase family 1 member B10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c2
aldo-keto reductase family 1, member C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Anxa1
annexin A1
ISO
RGD
PMID:23267026
RGD:7421573
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr13:22,689,783...22,853,920
G
Casp8
caspase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Ccl2
C-C motif chemokine ligand 2
ISO
protein:increased expression:serum (mouse)
RGD
PMID:22679019
RGD:9590167
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl27
C-C motif chemokine ligand 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 5:56,941,402...56,948,511
Ensembl chr 5:56,941,402...56,948,506
G
Ccn2
cellular communication network factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccr1
C-C motif chemokine receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 8:123,556,286...123,561,841
G
Cd44
CD44 molecule (Indian blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd46
CD46 molecule
ISO
RGD
PMID:12055630
RGD:6483467
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
G
Cd86
CD86 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cldn1
claudin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23136956
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12631246
NCBI chr10:89,040,203...89,083,481
Ensembl chr10:89,040,203...89,083,481
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
RGD
PMID:11348467
RGD:7421503
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Ctss
cathepsin S
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 2:183,089,192...183,114,483
Ensembl chr 2:183,086,437...183,114,483
G
Cxcl14
C-X-C motif chemokine ligand 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr17:8,317,933...8,325,956
Ensembl chr17:8,317,933...8,324,839
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Ddit3
DNA-damage inducible transcript 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Defb1
defensin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
G
Dusp1
dual specificity phosphatase 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25724174 PMID:23076500
RGD:7771535
NCBI chr10:16,680,489...16,683,276
G
Esr2
estrogen receptor 2
severity
ISO
RGD
PMID:18167605
RGD:8694123
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
F11r
F11 receptor
ISO
RGD
PMID:15343392
RGD:7488917
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
G
Fabp4
fatty acid binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 2:91,580,858...91,585,578
Ensembl chr 2:91,580,885...91,585,578
G
Flg
filaggrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 2:178,888,688...178,912,731
G
Fth1
ferritin heavy chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
G6pd
glucose-6-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gclc
glutamate-cysteine ligase, catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Glb1
galactosidase, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
G
Gsr
glutathione-disulfide reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gss
glutathione synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
G
Gstp1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Hdac4
histone deacetylase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
G
Hmox1
heme oxygenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hspb1
heat shock protein family B (small) member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Icam1
intercellular adhesion molecule 1
ISO
RGD
PMID:20182448
RGD:5685684
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Igfbp2
insulin-like growth factor binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
G
Igfbp6
insulin-like growth factor binding protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966
G
Il13
interleukin 13
treatment
ISO
RGD
PMID:19951958
RGD:8549563
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il4
interleukin 4
treatment
ISO
RGD
PMID:12188032
RGD:7829776
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Ing1
inhibitor of growth family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr16:77,937,276...77,945,320
Ensembl chr16:77,937,279...77,946,264
G
Kdr
kinase insert domain receptor
ISO
RGD
PMID:15500639
RGD:5684424
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kif2c
kinesin family member 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
G
Krt10
keratin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
G
Krt2
keratin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 7:132,941,275...132,947,963
Ensembl chr 7:132,940,862...132,947,963
G
Krt4
keratin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 7:133,046,067...133,052,027
Ensembl chr 7:133,046,515...133,052,019
G
Lcn2
lipocalin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lta
lymphotoxin alpha
ISO
RGD
PMID:11390430
RGD:8548819
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Ltb
lymphotoxin beta
ISO
RGD
PMID:11390430
RGD:8548819
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
G
Mlana
melan-A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 1:227,469,537...227,483,343
Ensembl chr 1:227,469,537...227,483,343
G
Mmp10
matrix metallopeptidase 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mmp8
matrix metallopeptidase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 8:4,724,009...4,732,956
Ensembl chr 8:4,724,029...4,733,520
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nqo2
N-ribosyldihydronicotinamide:quinone reductase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
G
Nrg1
neuregulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr16:59,250,658...60,303,024
Ensembl chr16:59,250,854...60,296,884
G
Osm
oncostatin M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
G
Pir
pirin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Prdx6
peroxiredoxin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
G
Psmd12
proteasome 26S subunit, non-ATPase 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr10:92,438,223...92,457,323
Ensembl chr10:92,438,298...92,457,287
G
RT1-DMa
RT1 class II, locus DMa
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18348411
NCBI chr20:4,707,028...4,710,432
Ensembl chr20:4,707,028...4,710,432
G
S100a8
S100 calcium binding protein A8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
Sell
selectin L
ISO
RGD
PMID:20182448
RGD:5685684
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Serpinb3
serpin family B member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr13:23,274,120...23,280,082
Ensembl chr13:23,274,484...23,313,682
G
Serpinb3a
serpin family B member 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr13:23,241,303...23,246,328
Ensembl chr13:23,236,972...23,246,985
G
Slc7a11
solute carrier family 7 member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod3
superoxide dismutase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17392825
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Stoml2
stomatin like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 5:57,256,227...57,259,824
Ensembl chr 5:57,256,220...57,259,920
G
Tlr4
toll-like receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18725520
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr8
toll-like receptor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr X:27,091,780...27,116,092
Ensembl chr X:27,091,778...27,116,549
G
Tnfsf9
TNF superfamily member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
G
Tpsab1
tryptase alpha/beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr10:14,360,396...14,362,811
Ensembl chr10:14,360,396...14,362,811
G
Txn1
thioredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txnrd1
thioredoxin reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 9:88,747,229...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25724174
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Xrcc1
X-ray repair cross complementing 1
susceptibility
ISO
associated with nasopharynx carcinoma;DNA:SNP:cds: p.R399Q (human)
RGD
PMID:23375119
RGD:150539032
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Cd14
CD14 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19759553
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd80
Cd80 molecule
ISO
DNA:SNP
RGD
PMID:22192168
RGD:6893665
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Dock8
dedicator of cytokinesis 8
ISO
DNA:mutations: :
RGD
PMID:22534316
RGD:40902960
NCBI chr 1:222,649,309...222,842,474
Ensembl chr 1:222,649,309...222,842,474
G
Flg
filaggrin
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Eczema
CTD ClinVar
PMID:16444271 PMID:16550169 PMID:16815158 PMID:17030239 PMID:17417636 PMID:17657246 PMID:18325573 PMID:19501237 PMID:19538357 PMID:19733298 PMID:19785597 PMID:19839980 PMID:19874431 PMID:20426775 PMID:20573035 PMID:21365004 PMID:21377035 PMID:21514438 PMID:21564328 PMID:21777221 PMID:22403702 PMID:22995991 PMID:23039796 PMID:23166590 PMID:23343419 PMID:23352160 PMID:23947670 PMID:23993222 PMID:24033266 PMID:24251354 PMID:24920311 PMID:25333069 PMID:25741868 PMID:26451970 PMID:27279822 PMID:27363669 PMID:27462351 PMID:28164424 PMID:28213896 PMID:28730607 PMID:29054605 PMID:29068602 PMID:29428354 PMID:29431110 PMID:29444371 PMID:29791750 PMID:30665703 PMID:31637781 More...
NCBI chr 2:178,888,688...178,912,731
G
Havcr2
hepatitis A virus cellular receptor 2
ISO
RGD
PMID:16159638
RGD:5128852
NCBI chr10:30,882,484...30,914,018
Ensembl chr10:30,882,606...30,909,137
G
Ifngr1
interferon gamma receptor 1
resistance
ISO
DNA: snps: rs7749390, rs10457655 DNA: insertion: exon 5: neo cassette
RGD
PMID:21458658 PMID:21458658
RGD:6480259 , RGD:6480259
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
G
Il13
interleukin 13
no_association
ISO
DNA:polymorphisms: :multiple DNA:SNP:CDS:p.R130Q (rs20541) (human)
RGD
PMID:18410415 PMID:23815671
RGD:8549512 , RGD:8549530
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il18
interleukin 18
ISO
DNA:SNPs:promoter, exon:multiple
RGD
PMID:15806006
RGD:8655937
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il4r
interleukin 4 receptor
susceptibility
ISO
DNA:SNP: : rs2057768 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19759553 PMID:20002627
RGD:4890389
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Itga3
integrin subunit alpha 3
ISO
ClinVar Annotator: match by term: Eczema
ClinVar
PMID:25741868
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
G
Plau
plasminogen activator, urokinase
ISO
RGD
PMID:19416247
RGD:6483821
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Stat4
signal transducer and activator of transcription 4
ISO
RGD
PMID:22192168
RGD:6893665
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
Xdh
xanthine dehydrogenase
ISO
ClinVar Annotator: match by term: Eczema
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Ido1
indoleamine 2,3-dioxygenase 1
severity
ISO
associated with atopic dermatitis; protein:increased activity:serum (human)
RGD
PMID:26198597
RGD:11528429
NCBI chr16:67,430,684...67,442,459
Ensembl chr16:67,430,578...67,442,730
G
Ifng
interferon gamma
susceptibility
ISO
mRNA,protein:decreased expression:peripheral mononuclear cell: DNA:haplotype::
RGD
PMID:21458658 PMID:21458658
RGD:6480259 , RGD:6480259
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Spink5
serine peptidase inhibitor, Kazal type 5
ISO
ClinVar Annotator: match by term: Erythroderma
ClinVar
PMID:15304086 PMID:19683336 PMID:21255986 PMID:22089833 PMID:22377713 PMID:25665175 PMID:25741868 PMID:26229701 PMID:28289593 PMID:28492532 More...
NCBI chr18:36,264,452...36,333,143
Ensembl chr18:36,264,452...36,332,185
G
Krt1
keratin 1
ISO
OMIM
NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:132,976,620...132,981,844
G
C2
complement C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27258892
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
G
Ier3
immediate early response 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27258892
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Il4
interleukin 4
IEP
RGD
PMID:19690449
RGD:2317271
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
LOC102556347
carbonyl reductase [NADPH] 1-like
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25818598
NCBI chr11:32,892,640...32,895,277
Ensembl chr11:32,857,991...32,895,275
G
RT1-Ha
RT1 class II, locus Ha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27258892
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
G
Stat3
signal transducer and activator of transcription 3
treatment
ISO
RGD
PMID:21511023
RGD:8694305
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Trim10
tripartite motif-containing 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27258892
NCBI chr20:1,689,554...1,698,948
Ensembl chr20:1,689,562...1,698,252
G
Trim31
tripartite motif-containing 31
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27258892
NCBI chr20:1,653,165...1,666,494
Ensembl chr20:1,653,165...1,666,494
G
Trim40
tripartite motif-containing 40
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27258892
NCBI chr20:1,676,188...1,685,906
Ensembl chr20:1,676,270...1,685,214
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16758956
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Bdkrb2
bradykinin receptor B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Foxp3
forkhead box P3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29477354
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29477354
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
ISO
RGD
PMID:19254288
RGD:8549579
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Kng2
kininogen 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
G
Nat1
N-acetyltransferase 1
susceptibility
ISO
DNA:polymorphisms:: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19834256 PMID:19834256
RGD:8552685
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
G
Nat2
N-acetyltransferase 2
susceptibility
ISO
DNA:polymorphisms:: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19834256 PMID:19834256
RGD:8552685
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
RT1-DMa
RT1 class II, locus DMa
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16737583
NCBI chr20:4,707,028...4,710,432
Ensembl chr20:4,707,028...4,710,432
G
Cdsn
corneodesmosin
ISO
CTD Direct Evidence: marker/mechanism
CTD
NCBI chr20:3,179,432...3,185,854
Ensembl chr20:3,179,438...3,184,250
G
Chst8
carbohydrate sulfotransferase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
NCBI chr 1:87,294,144...87,435,900
Ensembl chr 1:87,294,540...87,435,900
G
Serpinb8
serpin family B member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
NCBI chr13:23,626,945...23,650,270
Ensembl chr13:23,626,945...23,650,835
G
Cdsn
corneodesmosin
ISO
ClinVar Annotator: match by term: Peeling skin syndrome 1
OMIM ClinVar
PMID:2434123 PMID:20691404 PMID:21191406 PMID:22146835 PMID:23957618 PMID:25741868 PMID:28492532 More...
NCBI chr20:3,179,432...3,185,854
Ensembl chr20:3,179,438...3,184,250
G
Tgm5
transglutaminase 5
ISO
ClinVar Annotator: match by term: Peeling skin syndrome 1
ClinVar
PMID:22622422
NCBI chr 3:108,008,087...108,014,813 NCBI chr 3:108,028,742...108,048,946
Ensembl chr 3:108,008,143...108,043,976
G
Tgm5
transglutaminase 5
ISO
ClinVar Annotator: match by term: Acral peeling skin syndrome
OMIM ClinVar
PMID:16380904 PMID:19440220 PMID:20164844 PMID:21469335 PMID:22036214 PMID:22622422 PMID:24019772 PMID:24628291 PMID:25644735 PMID:25741868 PMID:26091878 PMID:26707537 PMID:26925801 PMID:28492532 PMID:29242947 More...
NCBI chr 3:108,008,087...108,014,813 NCBI chr 3:108,028,742...108,048,946
Ensembl chr 3:108,008,143...108,043,976
G
Chst8
carbohydrate sulfotransferase 8
ISO
ClinVar Annotator: match by term: Peeling skin syndrome 3
OMIM ClinVar
PMID:22289416 PMID:25741868 PMID:28492532
NCBI chr 1:87,294,144...87,435,900
Ensembl chr 1:87,294,540...87,435,900
G
Csta
cystatin A
ISO
ClinVar Annotator: match by term: Peeling skin syndrome 4
OMIM ClinVar
PMID:12890214 PMID:21944047 PMID:22066523 PMID:23534700 PMID:25400170
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
G
Serpinb8
serpin family B member 8
ISO
ClinVar Annotator: match by term: Peeling skin syndrome 5
OMIM ClinVar
PMID:25741868 PMID:27476651 PMID:28492532
NCBI chr13:23,626,945...23,650,270
Ensembl chr13:23,626,945...23,650,835
G
Flg2
filaggrin 2
ISO
ClinVar Annotator: match by term: Peeling skin syndrome 6
OMIM ClinVar
PMID:25741868 PMID:28884927 PMID:29505760 PMID:29758285
NCBI chr 2:178,789,792...178,802,232
G
Cast
calpastatin
ISO
ClinVar Annotator: match by term: Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads
OMIM ClinVar
PMID:3527073 PMID:25683118 PMID:25741868 PMID:28492532
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Erap1
endoplasmic reticulum aminopeptidase 1
ISO
ClinVar Annotator: match by term: Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads
ClinVar
PMID:3527073 PMID:25683118
NCBI chr 2:3,931,817...3,970,735
Ensembl chr 2:3,931,904...3,972,447
G
Cat
catalase
ISO
protein:increased activity:scalp:
RGD
PMID:24001414
RGD:9479166
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Tlr2
toll-like receptor 2
treatment
ISO
RGD
PMID:21566548
RGD:8553045
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all